Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

MRI-guided ablation as effective as surgery for prostate cancer treatment
A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors.
Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function
Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.
FDA approves smallest defibrillation lead of its kind for LBBA placement
The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.
How telehealth utilization among heart patients has evolved since the pandemic
The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.
Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits
When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial.

MRI-guided ablation as effective as surgery for prostate cancer treatment

A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors.

Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

OmniaSecure defibrillation lead approved by FDA for placement in LBB area

FDA approves smallest defibrillation lead of its kind for LBBA placement

The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.

Trends in telemedicine utilization from 2019-2024 for all Americans, Americans without atherosclerotic cardiovascular disease (ASCVD), and Americans With ASCVD.

How telehealth utilization among heart patients has evolved since the pandemic

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

artificial intelligence AI in healthcare

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial.

Workflow efficiencies and automation enhance newer cardiovascular IT systems

9 ways cardiovascular IT systems can improve your day-to-day workflow

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

overweight patient seeking health advice

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.

'Leaky' blood brain barrier causes long-term damage years after head injuries

MRI findings detail how a 'leaky' barrier can damage the brain years after head injuries

New evidence suggests the BBB can remain compromised following a head injury, even years after it first occurred.